November 10, 2022 Experience Roivant Sciences $150 million equity offering We advised the company on its debut SEC-registered primary and secondary offering
November 9, 2022 Experience Akoya Biosciences $50 million at-the-market program The common stock is listed on the Nasdaq Global Select Market
November 9, 2022 Experience Lucid $600 million at-the-market offering and $915 million additional investment The common stock is listed on Nasdaq
November 7, 2022 Experience Equinix $1.5 billion at-the-market offering We advised the company on the SEC-registered at-the-market offering
October 28, 2022 Experience PGE stock offering and forward sale agreement The stock is listed on the NYSE
October 24, 2022 Experience Denali Therapeutics $316 million follow-on offering The shares are listed on the Nasdaq Global Select Market
October 12, 2022 Experience Immatics $110 million follow-on offering We advised Immatics on the offering of shares
September 30, 2022 Experience Gamida Cell $20 million follow-on offering The shares are listed on the Nasdaq Global Select Market
September 30, 2022 Experience Solid Biosciences $75 million common stock PIPE offering The financing is taking place concurrently with the company’s acquisition of AavantiBio
September 27, 2022 Experience EDAP TMS $23 million follow-on offering The ADSs are listed on the Nasdaq Global Market